From: Joint media release with The Hon Christopher Pyne MP, Minister for Industry, Innovation and Science, Senator the Hon Simon Birmingham, Minister for Education and Training and the Hon Karen Andrews MP, Assistant Minister for Science.
A strategic partnership for manufacturing and R&D between the University of Adelaide and Trajan Scientific and Medical shows how research institutions and manufacturers can work together to power the National Innovation and Science Agenda’s ideas boom.
Scientists from the University’s Institute for Photonics and Advanced Sensing and the School of Physical Sciences will work with Trajan to commercialise their research into products that ultimately benefit human health and wellbeing.
At the partnership launch at the University, the Minister for Industry, Innovation and Science, Christopher Pyne, said the national agenda would create a climate in which similar relationships would thrive.
“Collaborations like this produce links that will enable researchers to work with industry, in this case an advanced manufacture can produce tangible outcomes from their work through products with wide-ranging medical and scientific applications,” Mr Pyne said.
“It’s an exciting alliance that demonstrates what the Agenda will achieve by placing science and innovation at the heart of transforming Australia’s economy with world-leading science, technology, engineering and mathematics (STEM) products and services.”
“This sort of manufacturing, of specialty glass products for the global science and medical equipment market, shows the importance of equipping Australians with appropriate job skills for the workforce of the 21st century.”
Photo(L-R): Dr Anne Collins, General Manager, Instruments, Sensors and Devices, Dr Herbert Foo, Principal Scientist, Photonics, Trajan Scientific and Medical, Senator the Hon Simon Birmingham, Minister for Education and Training, the Hon Karen Andrews MP, Assistant Minister for Science, and the Hon Christopher Pyne MP, Minister for Industry, Innovation and Science, Australia. Source: University of Adelaide
Trajan announces new Instruments, Sensors and Devices Business Unit at University of Adelaide
Federal and Victorian Industry Ministers announce Trajan as manufacturing grant recipient
Trajan welcomes Australian Prime Minister to showcase its ‘disruptive innovation’ with academia and start-ups
Trajan announces landmark collaboration in R&D and manufacturing with Australian academia and government
Media Contact Information
Trajan Scientific and Medical
+61 (0) 3 9837 4200
PR Consultancy: LBPR
+61 (0) 429 976 718
Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.
Trajan Scientific and Medical has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration as Class I for therapeutic and in vitro diagnostic use. This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.